Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 5/20 | 0.49 |
| ▸ | CA2 | P00918 | 5/20 | 0.49 |
| ▸ | CA12 | O43570 | 4/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.34 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.32 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7739748 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL12302011 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL13080340 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL7739258 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL7739256 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL13133631 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL12330761 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL332549 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL14038566 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL2441166 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114236008-B | Method for detecting content of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业股份有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-114236008-A | Method for detecting contents of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-108727440-B | Preparation method of 1,2, 3-tri-O-acetyl-5-deoxy-beta-D-ribose | 新乡拓新药业股份有限公司 | 2021-12-17 | — | — | CN | claimed |
| CN-108484690-B | Preparation method of 1,2, 3-tri-O-acetyl-5-deoxy-beta-D-ribose | 新乡拓新药业股份有限公司 | 2021-04-30 | — | — | CN | claimed |
| WO-2008105593-A1 | METHOD FOR STEREOSELECTIVE PREPARATION AND SEPARATION OF TRI-O-ACETYL-5-DEOXY-ß-D-RIBOFURANOSE | HANMI PHARM. CO., LTD. (KR) | 2008-09-04 | — | — | WO | claimed |
| CN-119874794-A | Preparation method of capecitabine with large granularity | 山东安信制药有限公司 | 2025-04-25 | — | — | CN | disclosed |
| WO-2024134541-A1 | HETEROCYCLIC COMPOUNDS AS ENT INHIBITORS AND COMPOUNDS FOR USE IN THE TREATMENT OF CANCERS | iTeos Belgium SA (BE) | 2024-06-27 | — | — | WO | disclosed |
| CN-114236008-B | Method for detecting content of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-114236008-B | Method for detecting content of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-114236008-A | Method for detecting contents of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-114236008-A | Method for detecting contents of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-108727440-B | Preparation method of 1,2, 3-tri-O-acetyl-5-deoxy-beta-D-ribose | 新乡拓新药业股份有限公司 | 2021-12-17 | — | — | CN | disclosed |
| EP-1303282-A1 | PYRIDO[2,3-D]PYRIMIDINE AND PYRIMIDO[4,5-D]PYRIMIDINE NUCLEOSIDES | Ribapharm, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002003997-A1 | PYRIDO[2,3-D]PYRIMIDINE AND PYRIMIDO[4,5-D]PYRIMIDINE NUCLEOSIDES | RIBAPHARM INC. (US) | 2002-01-17 | — | — | WO | disclosed |
| EP-0602478-B1 | Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives | HOFFMANN LA ROCHE (CH) | 1996-07-31 | — | — | EP | disclosed |
| EP-0602454-B1 | N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines | HOFFMANN LA ROCHE (CH) | 1996-04-24 | — | — | EP | disclosed |
| US-5472949-A | Antitumor agents | HOFFMANN-LA ROCHE INC. (US) | 1995-12-05 | — | — | US | disclosed |
| US-5360795-A | Treating cytomegalo virus and herpes simplex viruses | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1994-11-01 | — | — | US | disclosed |
| EP-0602454-A1 | N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines | F. HOFFMANN-LA ROCHE AG (CH) | 1994-06-22 | — | — | EP | disclosed |
| US-4056674-A | VIRICIDE, BACTERICIDE | ICN PHARMACEUTICALS, INC. (US) | 1977-11-01 | — | — | US | disclosed |